A tumor suppressor function for prosurvival BCL-2 proteins in the thymus
Genes & Development · 12.11.2026
DOI: 10.1101/gad.353558.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, online erschienen am 12.11.2026. Verfasst von Meng-Xiao Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia. Gefördert von: National Health and Medical Research Council, NHMRC Fellowship, NHMRC.
Abstract (Originalsprache)
Defective cell competition has been linked to tumorigenesis in various cancers, including acute lymphoblastic leukemia (T-ALL), but the underlying mechanisms remain unclear. In the thymus, we found marked elevation in the amount of prosurvival BCL-2 protein in “new” progenitors competing with “old” counterparts, suggesting an apoptotic mechanism. However, in a thymic transplant model of disrupted cell competition, Bcl2 deletion paradoxically accelerated the onset of leukemia resembling T-ALL. Mechanistically, the loss of BCL-2 did not alter competitive outcomes but induced heightened apoptosis and increased IL-7-driven compensatory proliferation in the surviving progenitors. This elevated cell turnover accelerated the acquisition of oncogenic mutations but did not change the mutational burden or landscape of T-ALL. More broadly, we found that even modest reduction in the related prosurvival proteins, MCL-1 or BCL-XL, also accelerated T-ALL-like disease in the transplant model. In a separate setting, conditional ablation of Mcl1 early in thymic lymphopoiesis caused profound thymocyte loss, elevated progenitor proliferation and spontaneous T-ALL. These findings define a tumor-suppressive function for BCL-2 family proteins in settings of defective cell competition, with important implications for the therapeutic use of BH3 mimetics in cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
- Department of Medical Biology, The University of Melbourne, Victoria 3052, Australia.
- Amgen Inc., Thousand Oaks, California 91320, USA.
- RayzeBio, San Diego, California 92121, USA.
- The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; dgray@wehi.edu.au.
Förderung
- National Health and Medical Research Council
- NHMRC Fellowship
- NHMRC
- Leukemia and Lymphoma Society-Specialized Center of Research
- Cancer Council of Victoria
- Leukemia Foundation Postgraduate Research Scholarship
- Postdoctoral Cancer Research Fellowship
- Cancer Council
Zitieren
APA
Luo, M. X., Policheni, A., Yan, F., Grabow, S., Zhao, K., Davidson, N. M., Teh, C. E., Strasser, A., & Gray, D. H. D. (2026). A tumor suppressor function for prosurvival BCL-2 proteins in the thymus. Genes & Development. https://doi.org/10.1101/gad.353558.125
Vancouver
Luo MX, Policheni A, Yan F, Grabow S, Zhao K, Davidson NM, et al. A tumor suppressor function for prosurvival BCL-2 proteins in the thymus. Genes & Development. 2026. doi:10.1101/gad.353558.125
BibTeX
@article{Luo2026,
author = {Luo, Meng-Xiao and Policheni, Antonia and Yan, Feng and Grabow, Stephanie and Zhao, Kelin and Davidson, Nadia M and Teh, Charis E and Strasser, Andreas and Gray, Daniel H D},
title = {A tumor suppressor function for prosurvival BCL-2 proteins in the thymus},
journal = {Genes & Development},
year = {2026},
doi = {10.1101/gad.353558.125}
}
EUVIMED